Rebecca Dunsmoor Su
Obstetrics & Gynecology · Morrisville, NCNPI 1386724359
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $39,704 of the $45,065 with a category attached, or 88.1%. 16 manufacturers reported payments, led by Novo Nordisk at 52.9% of the total. 2025 is the largest year on record at $29,718, more than ten times the $14 reported in 2021. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $738.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$24K
- Eli Lilly$10K
- Astellas Pharma US Inc$7K
- Novo Nordisk AS$2K
- Scynexis, Inc.$1K
- Incyte Corporation$510
- plus $924 from 10 others
Across 194 payments — averaging $4084.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exeltis, USA Inc.$271K
- Sumitomo Pharma America, Inc.$182K
- Incyte Corporation$110K
- Organon$70K
- AbbVie$59K
- Ironwood Pharmaceuticals, Inc$45K
- plus $57K from 3 others
What the payments were for
- Consulting fees$39,70488%
- Travel & lodging$2,9046%
- Food & beverage$2,4255%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $23,846 |
| Eli Lilly | 10 | $9,665 |
| Astellas Pharma US Inc | 11 | $7,385 |
| Novo Nordisk AS | 1 | $1,638 |
| Scynexis, Inc. | 2 | $1,098 |
| Incyte Corporation | 1 | $510 |
| Coopersurgical, Inc. | 2 | $239 |
| Astellas Pharma Global Development | 3 | $204 |
| Mayne Pharma Commercial LLC | 2 | $188 |
| Bayer | 2 | $112 |
| GSK | 1 | $43 |
| Agile Therapeutics, Inc. | 1 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $31 |
| AbbVie | 1 | $29 |
| Johnson & Johnson | 1 | $28 |
| Myovant Sciences Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$7,183
- PARAGARD T 380A$225
How this compares
$45,065 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Other obstetrics & gynecology in Morrisville
- Jerry MatkinsCharlotte$481K
- Laura McKainWilmington$475K
- Leslie Hansen-LindnerCharlotte$372K
- Robin MatthewsClyde$217K
- Haywood BrownDurham$165K
- Jack IngeRaleigh$157K
- Geeta SwamyDurham$142K
- Karie LafleurAsheville$135K
- Ty RobinsonHigh Point$114K
- Shan BiscetteCharlotte$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.